In the attempt to elucidate the mechanism of action of Bay 11-7082 with TMZ by which NF-κB subunits were modulated and to identify downstream signaling molecules, we employed RPPA platform using our drug treated or untreated patient-derived GBM cells. This evidence concerns the gene NFKB1 and glioblastoma.